Evidence map›Paper›PMID 31021124›Full record

ArticleHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2019

The role of patient beliefs in open-label placebo effects.

Kari A Leibowitz, Emerson J Hardebeck, J Parker Goyer, Alia J Crum

Open access · greenAbstract read
In one paragraph

Article in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. White patients' physical responses to healthcare treatments are influenced by provider race and gender.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Trial
  11. Trial
  12. Trial
  13. Effects of prefrontal transcranial direct current stimulation on open-label placebo responses.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kari A LeibowitzDepartment of Psychology.ORCID 0000-0001-7494-7270
Emerson J HardebeckDepartment of Psychology.
J Parker GoyerDepartment of Psychology.
Alia J CrumDepartment of Psychology.

Funding

Harnessing Mindset in 21st Century HealthcareDP2AT009511 · NCCIH · STANFORD UNIVERSITY · PI CRUM, ALIA · 2016 to 2016
$2.4M
NCCIH NIH HHS DP2 AT009511Sean N. Parker Allergy Center
6 · The paper itself

Abstract

objectiveRecent research on open-label placebos, or placebos administered without deception or concealment, suggests that they can be effective in a variety of conditions. The current research sought to unpack the mechanisms underlying the treatment efficacy of open-label placebos.

methodA health care provider induced an allergic reaction in 148 participants via a histamine skin prick test. Participants were then exposed to 1 of 4 conditions additively leveraging various mechanisms of open-label placebo treatments: a supportive patient-provider relationship, a medical ritual, positive expectations, and a rationale about the power of placebos.

resultsThere were no main effects of condition on allergic responses. However, participant beliefs about placebos moderated the effect of open-label placebo treatment condition on physiological allergic reactions: the condition including all 4 components of open-label placebos (a supportive patient-provider relationship, a medical ritual, positive expectations, and a rationale about the power of placebos) significantly reduced physiological allergic reaction among participants with a strong belief in placebos compared with participants in the control group.

conclusionParticipants' beliefs about placebos interact with information from the provider to reduce physiological allergic reactions in response to an open-label placebo treatment. This study underscores the importance of measuring and understanding how participants' beliefs influence outcomes of treatment, and furthers our understanding of when and how open-label placebo treatments work. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Indexed as

CultureDeceptionMotivationPlacebo EffectAdultFemaleHumansHypersensitivityMalePatient ParticipationResearch DesignTreatment Outcome

Identifiers

PMID31021124
PMCPMC7640758
OpenAlexW2941657921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.